17,018 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Bought by State of Alaska Department of Revenue

State of Alaska Department of Revenue acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 17,018 shares of the company's stock, valued at approximately $3,591,000. State of Alaska Department of Revenue owned 0.06% of Inspire Medical Systems as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in INSP. Baillie Gifford & Co. raised its stake in Inspire Medical Systems by 19.3% in the first quarter. Baillie Gifford & Co. now owns 1,467,613 shares of the company's stock valued at $315,229,000 after buying an additional 237,734 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Inspire Medical Systems during the first quarter worth approximately $3,113,000. BNP Paribas Financial Markets boosted its holdings in shares of Inspire Medical Systems by 89.4% in the 1st quarter. BNP Paribas Financial Markets now owns 2,297 shares of the company's stock valued at $493,000 after buying an additional 1,084 shares in the last quarter. Janney Montgomery Scott LLC grew its position in shares of Inspire Medical Systems by 32.8% in the 1st quarter. Janney Montgomery Scott LLC now owns 1,532 shares of the company's stock valued at $329,000 after buying an additional 378 shares during the last quarter. Finally, RiverPark Advisors LLC raised its stake in Inspire Medical Systems by 360.1% during the 1st quarter. RiverPark Advisors LLC now owns 773 shares of the company's stock worth $166,000 after acquiring an additional 605 shares in the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Truist Financial reaffirmed a "buy" rating and set a $240.00 price objective (up previously from $217.00) on shares of Inspire Medical Systems in a report on Monday, September 30th. Morgan Stanley reduced their price objective on Inspire Medical Systems from $250.00 to $210.00 and set an "overweight" rating for the company in a research note on Monday, July 15th. KeyCorp decreased their target price on shares of Inspire Medical Systems from $278.00 to $236.00 and set an "overweight" rating for the company in a research note on Wednesday, August 7th. Royal Bank of Canada restated an "outperform" rating and set a $260.00 price objective on shares of Inspire Medical Systems in a research report on Wednesday, August 7th. Finally, Robert W. Baird lowered their target price on shares of Inspire Medical Systems from $220.00 to $200.00 and set an "outperform" rating on the stock in a report on Wednesday, August 7th. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Inspire Medical Systems presently has an average rating of "Moderate Buy" and a consensus target price of $219.58.

Insider Buying and Selling

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the business's stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $220.00, for a total transaction of $176,000.00. Following the sale, the director now owns 23,140 shares in the company, valued at approximately $5,090,800. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Randy Ban sold 4,861 shares of the company's stock in a transaction on Friday, August 16th. The shares were sold at an average price of $188.55, for a total value of $916,541.55. Following the completion of the sale, the insider now directly owns 3,056 shares in the company, valued at approximately $576,208.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Shawn Mccormick sold 800 shares of the business's stock in a transaction on Monday, September 9th. The stock was sold at an average price of $220.00, for a total transaction of $176,000.00. Following the completion of the sale, the director now owns 23,140 shares of the company's stock, valued at $5,090,800. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,692 shares of company stock worth $1,099,207 in the last ninety days. 4.10% of the stock is currently owned by corporate insiders.

Inspire Medical Systems Trading Down 0.8 %

Inspire Medical Systems stock traded down $1.49 during midday trading on Thursday, hitting $195.07. The stock had a trading volume of 394,728 shares, compared to its average volume of 593,418. The business has a fifty day moving average price of $200.92 and a 200 day moving average price of $181.13. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40. The stock has a market cap of $5.80 billion, a P/E ratio of -357.95 and a beta of 1.34.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.46. Inspire Medical Systems had a return on equity of 1.03% and a net margin of 0.85%. The business had revenue of $195.89 million during the quarter, compared to analyst estimates of $189.08 million. During the same quarter in the previous year, the firm posted ($0.41) EPS. The business's revenue for the quarter was up 29.6% compared to the same quarter last year. On average, equities analysts anticipate that Inspire Medical Systems, Inc. will post 0.75 EPS for the current fiscal year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.